Literature DB >> 30560481

Spatial Training Ameliorates Long-Term Alzheimer's Disease-Like Pathological Deficits by Reducing NLRP3 Inflammasomes in PR5 Mice.

Qing-Guo Ren1, Wei-Gang Gong2, Hong Zhou3, Hao Shu3, Yan-Juan Wang3, Zhi-Jun Zhang3.   

Abstract

Recent studies have suggested that cognitive training could delay memory loss in Alzheimer's disease (AD). However, whether and how cognitive training produces long-term benefits remains unclear. Here, 10-month-old PR5 mice were spatially trained in a water maze for 4 consecutive weeks. The novel object recognition test (NORT), Western blots, Golgi staining, and ELISA were used to examine behavioral, biochemical, and pathological measures immediately after training and 3 months later. Immediately after training, we found that spatial training significantly improved cognitive performance; reduced tau neuropathology; increased the expression level of synaptophysin, PSD93, and PSD95 in the hippocampus; and increased the number of dendritic spines in PR5 mice. The expression levels of NLRP3, caspase-1, and interleukin (IL)-1β, which were significantly elevated in PR5 mice, were reversed by spatial training. Interestingly, these effects persisted 3 months later. To further detect the role of NLRP3 in spatial training, PR5/NLRP3-/- mice and PR5/NLRP3+/- mice were also used in our study. PR5/NLRP3-/- mice showed better cognitive performance than PR5 mice. After 1 week of spatial training, these changes (including those in expression levels of synaptophysin, PSD93, and PSD95; the number of dendritic spines; and caspase-1 and IL-1β content in PR5 mice) could be totally reversed in PR5/NLRP3-/- and PR5/NLRP3+/- mice. In addition, there was a positive correlation between NLRP3 content and the expression levels of caspase-1 and IL-1β. These results show an important role for the NLRP3/caspase-1/IL-1β axis in ameliorating the effect of spatial training on cognitive impairment in PR5 mice.

Entities:  

Keywords:  Alzheimer’s disease; NLRP3 inflammasome; Spatial training; synaptic plasticity

Mesh:

Substances:

Year:  2019        PMID: 30560481      PMCID: PMC6554388          DOI: 10.1007/s13311-018-00698-w

Source DB:  PubMed          Journal:  Neurotherapeutics        ISSN: 1878-7479            Impact factor:   7.620


  45 in total

1.  Hippocampal synaptic loss in early Alzheimer's disease and mild cognitive impairment.

Authors:  Stephen W Scheff; Douglas A Price; Frederick A Schmitt; Elliott J Mufson
Journal:  Neurobiol Aging       Date:  2005-11-09       Impact factor: 4.673

2.  Leisure activities and the risk of amnestic mild cognitive impairment in the elderly.

Authors:  J Verghese; A LeValley; C Derby; G Kuslansky; M Katz; C Hall; H Buschke; R B Lipton
Journal:  Neurology       Date:  2006-02-08       Impact factor: 9.910

3.  Efficacy of an evidence-based cognitive stimulation therapy programme for people with dementia: randomised controlled trial.

Authors:  Aimee Spector; Lene Thorgrimsen; Bob Woods; Lindsay Royan; Steve Davies; Margaret Butterworth; Martin Orrell
Journal:  Br J Psychiatry       Date:  2003-09       Impact factor: 9.319

4.  Interleukin-1 mediates pathological effects of microglia on tau phosphorylation and on synaptophysin synthesis in cortical neurons through a p38-MAPK pathway.

Authors:  Yuekui Li; Ling Liu; Steven W Barger; W Sue T Griffin
Journal:  J Neurosci       Date:  2003-03-01       Impact factor: 6.167

5.  Formation of neurofibrillary tangles in P301l tau transgenic mice induced by Abeta 42 fibrils.

Authors:  J Götz; F Chen; J van Dorpe; R M Nitsch
Journal:  Science       Date:  2001-08-24       Impact factor: 47.728

6.  Altered expression of synaptic proteins occurs early during progression of Alzheimer's disease.

Authors:  E Masliah; M Mallory; M Alford; R DeTeresa; L A Hansen; D W McKeel; J C Morris
Journal:  Neurology       Date:  2001-01-09       Impact factor: 9.910

7.  Tau filament formation in transgenic mice expressing P301L tau.

Authors:  J Götz; F Chen; R Barmettler; R M Nitsch
Journal:  J Biol Chem       Date:  2001-01-05       Impact factor: 5.157

8.  Environmental enrichment mitigates cognitive deficits in a mouse model of Alzheimer's disease.

Authors:  Joanna L Jankowsky; Tatiana Melnikova; Daniel J Fadale; Guilian M Xu; Hilda H Slunt; Victoria Gonzales; Linda H Younkin; Steven G Younkin; David R Borchelt; Alena V Savonenko
Journal:  J Neurosci       Date:  2005-05-25       Impact factor: 6.167

9.  Synaptic alterations in the vestibulocerebellar system in Alzheimer's disease--a Golgi and electron microscope study.

Authors:  S J Baloyannis; S L Manolidis; L S Manolidis
Journal:  Acta Otolaryngol       Date:  2000-03       Impact factor: 1.494

10.  Interleukin-1 mediates Alzheimer and Lewy body pathologies.

Authors:  W Sue T Griffin; Ling Liu; Yuekui Li; Robert E Mrak; Steven W Barger
Journal:  J Neuroinflammation       Date:  2006-03-16       Impact factor: 8.322

View more
  3 in total

1.  Effects and Mechanisms of Synaptotagmin-7 in the Hippocampus on Cognitive Impairment in Aging Mice.

Authors:  Yaru Xie; Kaining Zhi; Xianfang Meng
Journal:  Mol Neurobiol       Date:  2021-08-17       Impact factor: 5.590

2.  Acupuncture accelerates neural regeneration and synaptophysin production after neural stem cells transplantation in mice.

Authors:  Lan Zhao; Jian-Wei Liu; Bo-Hong Kan; Hui-Yan Shi; Lin-Po Yang; Xin-Yu Liu
Journal:  World J Stem Cells       Date:  2020-12-26       Impact factor: 5.326

3.  DI-3-n-butylphthalide mitigates stress-induced cognitive deficits in mice through inhibition of NLRP3-Mediated neuroinflammation.

Authors:  Xiu Chen; Juan-Ling He; Xue-Ting Liu; Na Zhao; Fan Geng; Meng-Meng Zhu; Gong-Ping Liu; Qing-Guo Ren
Journal:  Neurobiol Stress       Date:  2022-09-13
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.